AI/PURE Trademark
Trademark Overview
On Thursday, August 14, 2003, a trademark application was filed for AI/PURE with the United States Patent and Trademark Office. The USPTO has given the AI/PURE trademark a serial number of 78287226. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 4, 2004. This trademark is owned by Pharmanex LLC. The AI/PURE trademark is filed in the Pharmaceutical Products category with the following description:
Nutritional and dietary supplement
General Information
Serial Number | 78287226 |
Word Mark | AI/PURE |
Filing Date | Thursday, August 14, 2003 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, October 4, 2004 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Nutritional and dietary supplement |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 28, 2003 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pharmanex LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Provo, UT 84601 |
Trademark Events
Event Date | Event Description |
Monday, October 4, 2004 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, October 4, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Sunday, March 7, 2004 | NON-FINAL ACTION E-MAILED |
Wednesday, March 3, 2004 | ASSIGNED TO EXAMINER |